Cardinal Health stock gains on strong Q4 earnings and guidance

Published on 09/16/2026 at 17:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock trades below its August 11, 2026 52-week high after a double-digit 52-week performance and a Q4 2026 earnings beat. The company now guides adjusted EPS of USD 12.40 to 12.60 for fiscal 2027 with continued specialty-led growth.

Fotorealistisches Pharma-Distributionslager mit Gabelstapler und Mitarbeitern in Dublin Ohio — Cardinal Health Inc. betreibt ein modernes Pharma-Distributionslager in Dublin, Ohio – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock (ISIN US14149Y1082) is trading below its recent 52-week high after investors digested a strong set of fiscal Q4 2026 results and fresh guidance that point to continued earnings growth into fiscal 2027 as of September 16, 2026.

Q4 2026 earnings beat supports Cardinal Health stock

According to Barchart, Cardinal Health, Inc. reported its fiscal Q4 2026 results on August 11, 2026, posting adjusted earnings per share of USD 2.91, clearly above Wall Street expectations of USD 2.42 for the quarter.

The same overview from Barchart notes that quarterly revenue reached USD 63.7 billion in Q4 2026, missing Wall Street forecasts of USD 65.6 billion, so the company beat on profit despite softer top-line growth.

In addition, Barchart highlights that management guided for full-year fiscal 2027 adjusted EPS in a range of USD 12.40 to USD 12.60, which would represent continued growth compared with the prior year and underpins the bullish stance many analysts have taken on the shares.

Guidance, cash returns and balance-sheet moves

The Q4 2026 report showed that Cardinal Health is leaning on specialty distribution, at-home care and nuclear medicine to drive margin stability and earnings gains, according to Barchart.

Management returned USD 1.4 billion to shareholders via share buybacks over the recent period and raised its repurchase authorization by USD 5.0 billion to USD 6.4 billion in total, while also adding a USD 4.0 billion revolving credit facility that strengthens liquidity and financial flexibility, as detailed by Barchart.

For investors, this combination of EPS growth guidance, ongoing buybacks and expanded credit capacity is a key element of the investment story, even as management continues to flag input-cost pressures and regulatory risks as factors to watch, according to Barchart.

Stock performance and valuation context

In terms of share-price performance, Barchart reports that Cardinal Health stock is down 9.9% from its 52-week high of USD 258.30, which it reached on August 11, 2026, following the Q4 earnings release.

Despite that pullback from the peak, the shares have still gained 54.8% over the past 52 weeks, outperforming the State Street SPDR S&P Health Care Services ETF, which delivered 40.8% over the same period, based on data cited by Barchart.

On a year-to-date basis, Cardinal Health stock is up 13.2%, which lags the 29.1% year-to-date gain of the S&P Health Care Services ETF, illustrating that the bulk of the stock's outperformance versus its sector peers has come over the longer, 12-month horizon rather than in recent months, according to Barchart.

Analyst view and price targets

Wall Street remains broadly positive on Cardinal Health stock. The stock carries a consensus Strong Buy rating from 18 analysts who cover the company, and the mean price target of USD 270.88 implies potential upside of 16.4% from current levels, according to Barchart.

This analyst stance reflects confidence that the company can deliver on its fiscal 2027 adjusted EPS guidance range of USD 12.40 to USD 12.60, while maintaining margin stability and growing specialty and at-home segments, as summarized in the same analysis by Barchart.

Next earnings date and trading picture

Investors looking ahead will note that Cardinal Health's next earnings release is scheduled for October 29, 2026, according to recent data from Investing.com summarizing the company's Q4 2026 report and upcoming events.

The same Investing.com overview indicates that Cardinal Health shares recently traded around USD 232.65 on the New York Stock Exchange, with the stock positioned between its recent peak of USD 258.30 and the lower end of its 52-week trading range, as of mid-September 2026.